Outset Medical, Inc. Cost of Revenue
Outset Medical, Inc. (OM) reported Cost of Revenue of $18.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- Outset Medical, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $18.35M, a 6.13% decline year-over-year.
- Outset Medical, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $15.77M, a 15.62% decline year-over-year.
- Outset Medical, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $16.64M, a 11.10% decline year-over-year.
- Outset Medical, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $17.84M, a 5.33% decline year-over-year.
- Outset Medical, Inc. cost of goods and services sold for fiscal 2025 was $72.72M, a 3.20% decline from fiscal 2024.
- Outset Medical, Inc. cost of goods and services sold for fiscal 2024 was $75.13M, a 25.89% decline from fiscal 2023.
- Outset Medical, Inc. cost of goods and services sold for fiscal 2023 was $101.38M, a 3.93% increase from fiscal 2022.
- Outset Medical, Inc. cost of goods and services sold for fiscal 2022 was $97.54M, a 2.68% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.35M 10-Q · filed 2026-08-06 | $34.12M 10-Q · filed 2026-08-06 | $50.76M derived: sum of 3 quarters · filed 2026-08-06 | $68.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $15.77M 10-Q · filed 2026-05-07 | $32.41M derived: sum of 2 quarters · filed 2026-05-07 | $50.25M derived: sum of 3 quarters · filed 2026-05-07 | $69.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $34.48M derived: sum of 2 quarters · filed 2026-02-13 | $54.04M derived: sum of 3 quarters · filed 2026-08-06 | $72.72M 10-K · filed 2026-02-13 |
| 2025-09-30 | $17.84M 10-Q · filed 2025-11-10 | $37.39M derived: sum of 2 quarters · filed 2026-08-06 | $56.08M 10-Q · filed 2025-11-10 | $74.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $19.55M 10-Q · filed 2026-08-06 | $38.24M 10-Q · filed 2026-08-06 | $56.96M derived: sum of 3 quarters · filed 2026-08-06 | $75.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.69M 10-Q · filed 2026-05-07 | $37.41M derived: sum of 2 quarters · filed 2026-05-07 | $56.25M derived: sum of 3 quarters · filed 2026-05-07 | $73.86M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $18.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $37.57M derived: sum of 2 quarters · filed 2026-02-13 | $55.17M derived: sum of 3 quarters · filed 2026-02-13 | $75.13M 10-K · filed 2026-02-13 |
| 2024-09-30 | $18.85M 10-Q · filed 2025-11-10 | $36.45M derived: sum of 2 quarters · filed 2025-11-10 | $56.41M 10-Q · filed 2025-11-10 | $79.20M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $17.61M 10-Q · filed 2025-08-07 | $37.56M 10-Q · filed 2025-08-07 | $60.35M derived: sum of 3 quarters · filed 2026-02-13 | $83.56M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $19.95M 10-Q · filed 2025-05-08 | $42.75M derived: sum of 2 quarters · filed 2026-02-13 | $65.95M derived: sum of 3 quarters · filed 2026-02-13 | $94.29M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $22.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $46.00M derived: sum of 2 quarters · filed 2026-02-13 | $74.34M derived: sum of 3 quarters · filed 2026-02-13 | $101.38M 10-K · filed 2026-02-13 |
| 2023-09-30 | $23.20M 10-Q · filed 2024-11-07 | $51.54M derived: sum of 2 quarters · filed 2024-11-07 | $78.58M 10-Q · filed 2024-11-07 | $105.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $28.34M 10-Q · filed 2024-08-08 | $55.38M 10-Q · filed 2024-08-08 | $82.11M derived: sum of 3 quarters · filed 2025-02-28 | $105.53M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $27.04M 10-Q · filed 2024-05-09 | $53.77M derived: sum of 2 quarters · filed 2025-02-28 | $77.20M derived: sum of 3 quarters · filed 2025-02-28 | $98.47M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $26.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $50.16M derived: sum of 2 quarters · filed 2025-02-28 | $71.43M derived: sum of 3 quarters · filed 2025-02-28 | $97.54M 10-K · filed 2025-02-28 |
| 2022-09-30 | $23.43M 10-Q · filed 2023-11-08 | $44.70M derived: sum of 2 quarters · filed 2023-11-08 | $70.81M 10-Q · filed 2023-11-08 | $95.64M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $21.27M 10-Q · filed 2023-08-03 | $47.38M 10-Q · filed 2023-08-03 | $72.21M derived: sum of 3 quarters · filed 2024-02-21 | $95.59M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $26.11M 10-Q · filed 2023-05-04 | $50.94M derived: sum of 2 quarters · filed 2024-02-21 | $74.31M derived: sum of 3 quarters · filed 2024-02-21 | $98.47M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $24.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $48.20M derived: sum of 2 quarters · filed 2024-02-21 | $72.37M derived: sum of 3 quarters · filed 2024-02-21 | $94.99M 10-K · filed 2024-02-21 |
| 2021-09-30 | $23.37M 10-Q · filed 2022-11-09 | $47.54M derived: sum of 2 quarters · filed 2022-11-09 | $70.16M 10-Q · filed 2022-11-09 | $86.99M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $24.16M 10-Q · filed 2022-08-02 | $46.79M 10-Q · filed 2022-08-02 | $63.62M derived: sum of 3 quarters · filed 2023-02-13 | $82.50M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $22.63M 10-Q · filed 2022-05-05 | $39.46M derived: sum of 2 quarters · filed 2023-02-13 | $58.34M derived: sum of 3 quarters · filed 2023-02-13 | $74.84M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | $16.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $35.71M derived: sum of 2 quarters · filed 2023-02-13 | $52.22M derived: sum of 3 quarters · filed 2023-02-13 | $62.97M 10-K · filed 2023-02-13 |
| 2020-09-30 | $18.88M 10-Q · filed 2021-11-04 | $35.39M derived: sum of 2 quarters · filed 2021-11-04 | $46.14M 10-Q · filed 2021-11-04 | $56.01M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $16.51M 10-Q · filed 2021-08-06 | $27.26M 10-Q · filed 2021-08-06 | $37.13M derived: sum of 3 quarters · filed 2022-02-23 | $45.05M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $10.75M 10-Q · filed 2021-05-06 | $20.62M derived: sum of 2 quarters · filed 2022-02-23 | $28.54M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2019-12-31 | $9.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $17.79M derived: sum of 2 quarters · filed 2022-02-23 | $32.88M 10-K · filed 2022-02-23 | |
| 2019-09-30 | $7.92M 10-Q · filed 2020-11-12 | $23.02M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $8.12M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |